The neurobiology of long COVID

Neurotoxic reactive astrocytes are induced by activated microglia

Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China

Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166

A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease

Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493

Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages

Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175

Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner

Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089

Complement and microglia mediate early synapse loss in Alzheimer mouse models

Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 2×

The Classical Complement Cascade Mediates CNS Synapse Elimination

Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101019 · Cited by 2,881

Long-term cognitive impairment after critical illness

Pandharipande, P. P., Girard, T. D., Jackson, J. C., Morandi, A., Thompson, J. L., Pun, B. T., Brummel, N. E., Hughes, C. G., Vasilevskis, E. E., Shintani, A. K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301372 · Cited by 2,842

Neurologic features in severe SARS-CoV-2 infection

Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674

Long COVID as a disease of accelerated biological aging: An opportunity to translate geroscience interventions

Shafqat, A., Masters, M. C., Tripathi, U., Tchkonia, T., Kirkland, J. L., & Hashmi, S. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102400 · Cited by 15

Effects of an 8‐week high‐dose vitamin D supplementation on fatigue and neuropsychiatric manifestations in post‐ COVID syndrome: A randomized controlled trial

Charoenporn, V., Tungsukruthai, P., Teacharushatakit, P., Hanvivattanakul, S., Sriyakul, K., Sukprasert, S., Kamalashiran, C., Tungsukruthai, S., & Charernboon, T. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13716 · Cited by 19

Exploring viral neuropathic pain: Molecular mechanisms and therapeutic implications

Xu, S., Li, H., Ai, Z., Guo, R., Cheng, H., & Wang, Y. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012397 · Cited by 15

Cognitive Aspects of COVID-19

Gonzalez‐Fernandez, E., & Huang, J. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01286-y · Cited by 15

Psychometric properties and observational data for COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) for post-COVID-19 syndrome

Kustura, L., Bobek, D., Poljičanin, A., Pavelin, S., Šoda, M. B., Šoda, J., Aksentijević, J., Glavor, K. D., Knez, N. N., Viali, V., et al. (2023) · QJM · doi:10.1093/qjmed/hcad224 · Cited by 14

AllergoOncology : Biomarkers and refined classification for research in the allergy and glioma nexus—A joint EAACI‐EANO position paper

Turner, M. C., Radzikowska, U., Ferastraoaru, D. E., Pascal, M., Wesseling, P., McCraw, A. J., Backes, C., Bax, H. J., Bergmann, C., Bianchini, R., et al. (2024) · Allergy · doi:10.1111/all.15994 · Cited by 14

Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects

Zhang, Y., Chen, S., Tian, Y., & Fu, X. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1407261 · Cited by 16

The Role of ACE2 in Neurological Disorders: From Underlying Mechanisms to the Neurological Impact of COVID-19

Li, J., Kong, X., Liu, T., Xian, M., & Wei, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189960 · Cited by 17

Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions

Lok, L. S. C., Sarkar, S., Lam, C. C. I., Law, C., Chau, S. T., Leung, C. Y. T., Cheang, W. H., Li, T., Monteiro, O., & Baptista‐Hon, D. T. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.70004 · Cited by 16

Phase-dependent trends in the prevalence of myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) related to long COVID: A criteria-based retrospective study in Japan

Morita, S., Tokumasu, K., Otsuka, Y., Honda, H., Nakano, Y., Sunada, N., Sakurada, Y., Matsuda, Y., Soejima, Y., Ueda, K., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315385 · Cited by 14

High Homocysteine Levels Are Associated with Cognitive Impairment in Patients Who Recovered from COVID-19 in the Long Term

Öner, P., Yılmaz, S. A., & Doğan, S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030503 · Cited by 14

Lowered Delta Activity in Post-COVID-19 Patients with Fatigue and Cognitive Impairment

Ortelli, P., Quercia, A., Cerasa, A., Dezi, S., Ferrazzoli, D., Sebastianelli, L., Saltuari, L. L., Versace, V., & Quartarone, A. (2023) · Biomedicines · doi:10.3390/biomedicines11082228 · Cited by 14

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

Taquet, M., Skórniewska, Z., Zetterberg, H., Geddes, J. R., Mummery, C. J., Chalmers, J. D., Ho, L., Horsley, A. R., Marks, M., Poinasamy, K., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad357 · Cited by 16

A year in review: brain barriers and brain fluids research in 2022

Keep, R. F., Jones, H. C., Hamilton, M. G., & Drewes, L. R. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00429-0 · Cited by 36

Fatigue during acute systemic inflammation is associated with reduced mental effort expenditure while task accuracy is preserved

Lambregts, B., Vassena, E., Jansen, A. F. M., Stremmelaar, D. E., Pickkers, P., Kox, M., Aarts, E., & van der Schaaf, M. E. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.05.013 · Cited by 15

Long‐term neurological dysfunction associated with COVID ‐19: Lessons from influenza and inflammatory diseases?

Volk, P., Manesh, M. R., Warren, M. E., Besko, K., de Andrade, E. G., Wicki‐Stordeur, L. E., & Swayne, L. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16016 · Cited by 14

Investigating the structural network underlying brain-immune interactions using combined histopathology and neuroimaging: a critical review for its relevance in acute and long COVID-19

Kikinis, Z., Castañeyra-Perdomo, A., González–Mora, J. L., Rushmore, J., Toppa, P. H., Haggerty, K., Papadimitriou, G., Yogesh Rathi, A., Kubicki, M. R., Kikinis, R., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1337888 · Cited by 13

Long COVID Is Not a Functional Neurologic Disorder

Davenport, T. E., Blitshteyn, S., Clague-Baker, N., Davies‐Payne, D., Treisman, G. J., & Tyson, S. F. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14080799 · Cited by 13

Clinical and Immunologic Effects of Paraprobiotics in Long-COVID Patients

Docampo, M. J., Batruch, M., Oldrati, P., Berenjeno‐Correa, E., Hilty, M., Leventhal, G. E., Lutterotti, A., Martinꝉ, R., & Sospedra, M. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200296 · Cited by 14

Neurological, psychological, psychosocial complications of long-COVID and their management

Narayanan, S. N., Padiyath, S., Chandrababu, K., Raj, L., Baby Chakrapani, P. S., Ninan, G. A., Sivadasan, A., Jacobs, A. R., Li, Y. W., & Bhaskar, A. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07854-5 · Cited by 17

Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damage

Boesl, F., Goereci, Y., Schweitzer, F., Finke, C., Schild, A., Bittner, S., Steffen, F., Schröder, M., Quitschau, A., Heine, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-55881-1 · Cited by 14

The impact of gut microbiome and diet on post-acute sequelae of SARS-CoV-2 infection

Reyes, Z., Stovall, M. C., Punyamurthula, S., Longo, M. T., Maraganore, D. M., & Solch-Ottaiano, R. J. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123295 · Cited by 13

Influences of sex and gender on the associations between risk and protective factors, brain, and behavior

Brosch, K., & Dhamala, E. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00674-4 · Cited by 14

Cognition, Cytokines, Blood–Brain Barrier, and Beyond in COVID-19: A Narrative Review

Barajas, A., Alacid, G. R., Vera-Montecinos, A., & Ramos, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010546 · Cited by 10

Intrinsic factors behind long‐COVID: II. SARS‐CoV‐2, extracellular vesicles, and neurological disorders

El‐Maradny, Y. A., Rubio‐Casillas, A., Mohamed, K. I., Uversky, V. N., & Redwan, E. M. M. M. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30486 · Cited by 10

Transforming Niclosamide through Nanotechnology: A Promising Approach for Long COVID Management

Rejinold, N. S., Choi, G., Jin, G., & Choy, J. (2025) · Small · doi:10.1002/smll.202410345 · Cited by 11

The Long Road of Long COVID: Specific Considerations for the Allergist/Immunologist

Bellanti, J. A., Novák, P., Faitelson, Y., Bernstein, J. A., & Castells, M. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.09.014 · Cited by 11

Long-COVID-19: the persisting imprint of SARS-CoV-2 infections on the innate immune system

Boes, M. L., & Falter‐Braun, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01717-9 · Cited by 10

Cardiopulmonary rehabilitation’s influence on cognitive functions, psychological state, and sleep quality in long COVID-19 patients: A randomized controlled trial

Gaudreau-Majeau, F., Gagnon, C., Clavet, S., Bérubé, B., Malo, J., Iglesies‐Grau, J., Gayda, M., Bherer, L., & Besnier, F. (2024) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2024.2338613 · Cited by 10

Multimodal neuroimaging exploration of the mechanisms of sleep quality deterioration after SARS-CoV-2 Omicron infection

Du, Y., Li, C., Zhao, W., Li, J., Zhao, L., Guo, H., Jiang, Y., Liu, W. V., Zeng, S., Zhang, H., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03487-9 · Cited by 10

A novel combined nomogram for predicting severe acute lower respiratory tract infection in children hospitalized for RSV infection during the post-COVID-19 period

Liu, H., Zhang, X.-Z., Liu, C.-Y., Li, W., Li, W., Wang, Y., Li, H.-Y., Xiang, M., Lu, R., Yuan, T.-Y., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1437834 · Cited by 10

Albumin in Normovolemic Fluid Management for Severe Traumatic Brain Injury: Controversies and Research Gaps

Wiedermann, C. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185452 · Cited by 11

Systemic cytokines related to memory function 6–9 months and 12–15 months after SARS-CoV-2 infection

Nuber‐Champier, A., Bréville, G., Voruz, P., de Alcântara, I. J., Cionca, A., Allali, G., Lalive, P. H., Benzakour, L., Lövblad, K., Braillard, O., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-72421-z · Cited by 10

COVID-19 and Cognitive Change in a Community-Based Cohort

Demmer, R. T., Cornelius, T. M., Kraal, A. Z., Pike, J. R., Sun, Y., Balte, P., Wu, C., Allen, N. B., Cushman, M., Suchy‐Dicey, A. M., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.18648 · Cited by 11

Ox-inflammasome involvement in neuroinflammation

Vallese, A., Cordone, V., Pecorelli, A., & Valacchi, G. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.010 · Cited by 13

Cognitive functions in COVID-19 survivors, approaches strategies, and impact on health systems: a qualitative systematic review

Espinoza, C. S., & Martella, D. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01662-2 · Cited by 10

Smartphone-based evaluation of static balance and mobility in long-lasting COVID-19 patients

Corrêa, B. D. C., Santos, E. G. R., Belgamo, A., Pinto, G. H. L., Xavier, S. S., Silva, C. C., Dias, Á. R. N., Paranhos, A. C. M., Cabral, A. D. S., Callegari, B., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1277408 · Cited by 10

Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care

Zifko, U., Guendling, K., Seet, R. C. S., & Kasper, S. F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1338235 · Cited by 10

The Power of Time: Editorial on the Advantages of Electroencephalography (EEG) and Event-Related Potentials (ERPs) in Affective and Cognitive Neuroscience

Walla, P. (2025) · Brain Sciences · doi:10.3390/brainsci15101054 · Cited by 10

A Gene Cluster of Mitochondrial Complexes Contributes to the Cognitive Decline of COVID-19 Infection

Xu, W., An, X., Chen, M.-J., Ma, J., Wang, X.-Q., Yang, J.-N., Wang, Q., Wang, D., Wu, Y., Zeng, L., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04471-3 · Cited by 8

Astrogliosis Marker [11C]SL25.1188 After COVID-19 With Ongoing Depressive and Cognitive Symptoms

Braga, J., Kuik, E. J. Y., Lepra, M., Rusjan, P., Kish, S. J., Vieira, É. L. M., Nasser, Z., Verhoeff, N., Vasdev, N., Chao, T. W.-C., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.09.027 · Cited by 9

Long COVID – a critical disruption of cholinergic neurotransmission?

Leitzke, M., Roach, D. T., Hesse, S., Schönknecht, P. O. D., Becker, G., Rullmann, M., Sattler, B., & Sabri, O. (2025) · Bioelectronic Medicine · doi:10.1186/s42234-025-00167-8 · Cited by 9

Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells and bodily fluids

Broderick, K., Moutaoufik, M. T., Saccon, T. D., Malty, R. H., Amin, S., Phanse, S., Joseph, T. P., Zilocchi, M., Hosseinnia, A., Istace, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60949-1 · Cited by 9

Behavioral and Sleep Disorders in Children and Adolescents following COVID-19 Disease: A Case-Control Study

del Giudice, M. M., Klain, A., Dinardo, G., D’Addio, E., Bencivenga, C. L., Fontanella, C., Decimo, F., Umano, G. R., Siciliano, M., Carotenuto, M., et al. (2023) · Children · doi:10.3390/children10071189 · Cited by 11

Understanding the Immune-Endocrine Effects of Vitamin D in SARS-CoV-2 Infection: A Role in Protecting against Neurodamage

Gotelli, E., Soldano, S., Hysa, E., Casabella, A., Cere, A., Pizzorni, C., Paolino, S., Sulli, A., Smith, V. M., & Cutolo, M. (2023) · NeuroImmunoModulation · doi:10.1159/000533286 · Cited by 9

Microglia influence immune responses and restrict neurologic disease in response to central nervous system infection by a neurotropic murine coronavirus

Syage, A. R., Pachow, C., Cheng, Y., Mangale, V., Green, K. N., & Lane, T. E. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1291255 · Cited by 9

Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19

Williams, G. P., Yu, E. D., Shapiro, K., Wang, E. W., Freuchet, A., Frazier, A., Arlehamn, C. S. L., Sette, A., & Antunes, R. D. S. (2024) · Human Immunology · doi:10.1016/j.humimm.2024.110770 · Cited by 9

The Effect of Sex on the Risk of Long-COVID and Cardiovascular Complications in Healthy Patients without Comorbidities: Data from a Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study

Bielecka-Dabrowa, A. M., Sakowicz, A., Gryglewska-Wawrzak, K., Kapusta, J., Banach, M., Jankowski, P., & Chudzik, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061559 · Cited by 10

Persistence of COVID-19 Symptoms and Quality of Life at Three and Twelve Months after Hospital Discharge

Gutiérrez-Canales, L. G., Muñoz-Corona, C., Barrera-Chávez, I., Viloria-Álvarez, C., Macías, A. E., Martínez-Navarro, L. J., Alvarez, J. A., Scavo-Montes, D. A., & Guaní-Guerra, E. (2024) · Medicina · doi:10.3390/medicina60060944 · Cited by 10

COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections

Maple, P. A. C. (2023) · Vaccines · doi:10.3390/vaccines11020232 · Cited by 9

Does Microglial Activation Lead to Cognitive Changes After COVID-19 Infection?

Gerhard, A. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.0664 · Cited by 9

Flow cytometry for extracellular vesicle characterization in COVID-19 and post-acute sequelae of SARS-CoV-2 infection

Fanelli, M., Petrone, V., Chirico, R., Radu, C. M., Minutolo, A., & Matteucci, C. (2024) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2024.20 · Cited by 9

Causal relationships between susceptibility and severity of COVID-19 and neuromyelitis optica spectrum disorder (NMOSD) in European population: a bidirectional Mendelian randomized study

Wang, S., Wang, L., Wang, J., & Zhu, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305650 · Cited by 8

COVID-19 related neurological manifestations in Parkinson’s disease: has ferroptosis been a suspect?

Jia, F., & Han, J. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01915-6 · Cited by 9

Long COVID: cognitive, balance, and retina manifestations

Carmona-Cervelló, M., León-Gómez, B. B., Dacosta‐Aguayo, R., Lamonja-Vicente, N., Montero-Alía, P., Molist, G., Ayet, A., Chacón, C., Costa-Garrido, A., López-Lifante, V. M., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1399145 · Cited by 12

A Disease Hidden in Plain Sight: Pathways and Mechanisms of Neurological Complications of Post-acute Sequelae of COVID-19 (NC-PASC)

Saxena, A., & Mautner, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04421-z · Cited by 10

High Somatization Rates, Frequent Spontaneous Recovery, and a Lack of Organic Biomarkers in Post‐Covid‐19 Condition

Tröscher, A. R., Gebetsroither, P., Rindler, M., Böhm, V., Dormann, R., von Oertzen, T. J., Heidbreder, A., Helbok, R., & Wagner, J. N. (2024) · Brain and Behavior · doi:10.1002/brb3.70087 · Cited by 8

Applying Lessons From Rheumatology to Better Understand Long COVID

Goldenberg, D. L. (2023) · Arthritis Care & Research · doi:10.1002/acr.25210 · Cited by 8

Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?

Bauer, L., & van Riel, D. A. J. (2023) · mBio · doi:10.1128/mbio.02920-22 · Cited by 9

SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptidePreprint

Larsson, J. N. K., Hellstrand, E., Hammarström, P., & Nyström, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.01.555834 · Cited by 9

3D Holo-tomographic Mapping of COVID-19 Microclots in Blood to Assess Disease Severity

Bergaglio, T., Synhaivska, O., & Nirmalraj, P. N. (2024) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.3c00126 · Cited by 11

Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial

Franke, C., Raeder, V., Boesl, F., Bremer, B., Adam, L. C., Gerhard, A., Eckert, I., Quitschau, A., Pohrt, A., Burock, S., et al. (2024) · Neurological Research and Practice · doi:10.1186/s42466-024-00311-w · Cited by 7

“A bit of a cough, tired, not very resilient – is that already Long-COVID?” perceptions and experiences of GPs with Long-COVID in year three of the pandemic. a qualitative interview study in Austria

Wojczewski, S., Mayrhofer, M., Szabo, N., Rabady, S., & Hoffmann, K. (2024) · BMC Public Health · doi:10.1186/s12889-024-20475-z · Cited by 7

Health Resort Treatment Mitigates Neuropsychiatric Symptoms in Long COVID Patients: A Retrospective Study

Onik, G., Knapik, K., Górka, D., & Sieroń–Stołtny, K. (2025) · Healthcare · doi:10.3390/healthcare13020196 · Cited by 7

Exploring the experiences of cognitive symptoms in Long COVID: a mixed-methods study in the UK

Miller, A., Song, N., Sivan, M., Chowdhury, R., & Burke, M. R. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-084999 · Cited by 7

Risk factors for fatigue severity in the post-COVID-19 condition: A prospective controlled cohort study of nonhospitalised adolescents and young adults

Selvakumar, J. P., Havdal, L. B., Brodwall, E. M., Sommen, S. L., Berven, L. L., Stiansen-Sonerud, T., Cvejic, E., & Wyller, V. B. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.100967 · Cited by 7

Pattern Recognition Receptors (PRRs) Expression and Activation in COVID-19 and Long COVID: From SARS-CoV-2 Escape Mechanisms to Emerging PRR-Targeted Immunotherapies

Maddaloni, L., Bugani, G., Fracella, M., Bitossi, C., D’Auria, A., Aloisi, F., Azri, A., Santinelli, L., M’hadheb-Gharbi, M. B., Pierangeli, A., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13092176 · Cited by 8

Neurological Dysfunction in Long COVID Should Not Be Labelled as Functional Neurological Disorder

Feltz-Cornelis, C. M. V. D., Moriarty, A. S., & Strain, W. D. (2023) · Viruses · doi:10.3390/v15030783 · Cited by 7

Organ-specific immunity: A tissue analysis framework for investigating local immune responses to SARS-CoV-2

Ng, A. H. C., Hu, H., Wang, K., Scherler, K., Warren, S. E., Zollinger, D. R., McKay-Fleisch, J., Sorg, K., Beechem, J., Ragaglia, E., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113212 · Cited by 7

Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities

León-Moreno, L. C., Reza-Zaldívar, E. E., Hernández-Sapiéns, M. A., Villafaña-Estarrón, E., García-Martín, M. C., Ojeda-Hernández, D. D., Matías‐Guiu, J. A., Gómez‐Pinedo, U., Matías‐Guiu, J., & Canales-Aguirre, A. A. (2023) · Biomolecules · doi:10.3390/biom14010008 · Cited by 8

Tracts in the limbic system show microstructural alterations post COVID-19 recovery

Mishra, S. S., Pedersini, C. A., Misra, R., Gandhi, T. K., Rokers, B., & Biswal, B. B. (2024) · Brain Communications · doi:10.1093/braincomms/fcae139 · Cited by 9

Structural and functional brain markers of cognitive impairment in healthcare workers following mild SARS-CoV-2 infection during the original stream

González-Rosa, J. J., Gómez-Molinero, M. P., Lozano-Soto, E., Fernández-Rosa, S. P., Campos-Silvo, M., García-Rodríguez, M. P., Cano-Cano, F., Sanmartino, F., Rashid-López, R., Macías-García, P., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae340 · Cited by 6

Beyond acute infection: mechanisms underlying post‐acute sequelae of COVID ‐19 ( PASC )

Adhikari, A., Maddumage, J. C., Eriksson, E. M., Annesley, S. J., Lawson, V., Bryant, V. L., & Gras, S. (2024) · The Medical Journal of Australia · doi:10.5694/mja2.52456 · Cited by 10

Serum angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients

Rodriguez-Perez, A. I., Serrano‐Heras, G., Labandeira, C. M., Camacho-Meño, L., Castro‐Robles, B., Suárez-Quintanilla, J. A., Muñoz, M., Landete, P. P., Guerra, M. J., Segura, T., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1571027 · Cited by 7

Prevalence and severity of neurologic symptoms in Long-COVID and the role of pre-existing conditions, hospitalization, and mental health

Huff, H. V., Roberts, H., Bartrum, E. A., Norato, G., Grayson, N. E., Fleig, K., Wilkerson, M. J., Stussman, B. J., Nath, A., & Walitt, B. T. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1562084 · Cited by 6

Functional brain abnormalities in post COVID-19 condition and their relationship with cognition

Carreras-Vidal, L., Pacheco-Jaime, L., Ariza, M., Cano, N., Garolera, M., Garcia-Vicente, C., Roura, I., Capdevila-Lacasa, C., Oltra, J., Pardo, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-00739-3 · Cited by 11

Post COVID-19 condition phenotypes: A prospective cohort study identifying four symptom clusters and their impact on long-term outcomes

Grafström, T., Barros, G. W. F., Persson, I.-L., Sundh, J., Forsell, M. N. E., Ahlm, C., Månsson, E., Tevell, S., Lind, A., Normark, J., et al. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102994 · Cited by 6

Inflammatory Response and Defects on Myelin Integrity in the Olfactory System of K18hACE2 Mice Infected with SARS-CoV-2

Martín-López, E., Brennan, B., Mao, T., Spence, N. J., Meller, S. J., Han, K., Yahiaoui, N., Wang, C., Iwasaki, A., & Greer, C. A. (2024) · eNeuro · doi:10.1523/eneuro.0106-24.2024 · Cited by 6

BMI changes among U.S. Navy and Marine Corps active-duty service members during the COVID-19 pandemic, 2019–2021

Janvrin, M. L., Banaag, A. L., Landry, T., Vincent, C., & Koehlmoos, T. P. (2024) · BMC Public Health · doi:10.1186/s12889-024-19699-w · Cited by 6

Interpretation of Neurodegenerative GWAS Risk Alleles in Microglia and their Interplay with Other Cell Types

Holtman, I. R., Glass, C. K., & Nott, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_29 · Cited by 6

Olfactory Development and Dysfunction: Involvement of Microglia

Meller, S. J., & Greer, C. A. (2024) · Physiology · doi:10.1152/physiol.00037.2024 · Cited by 6

Nanotechnology Assisted Strategies to Tackle COVID and Long-COVID

Aadil, K. R., Bhange, K., Mishra, G., Sahu, A., Sharma, S., Pandey, N., Mishra, Y. K., Kaushik, A. K., & Kumar, R. (2025) · BioNanoScience · doi:10.1007/s12668-025-01812-x · Cited by 7

Insights on the neurocognitive mechanisms underlying hippocampus-dependent memory impairment in COVID-19

Meyer, P., & Zaiser, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-04166-2 · Cited by 7

Attentional impairment and altered brain activity in healthcare workers after mild COVID-19

Lin, K., Gao, Y., Ji, W., Li, Y., Wang, W., Du, M., Liu, J., Hong, Z., Jiang, T., & Wang, Y. (2024) · Brain Imaging and Behavior · doi:10.1007/s11682-024-00851-4 · Cited by 6

Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection

Romani, A., Sergi, D., Zauli, E., Voltan, R., Lodi, G., Vaccarezza, M., Caruso, L., Previati, M., & Zauli, G. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1152254 · Cited by 6

Neurobiology of long-COVID: Hypotheses and unanswered questions

Simonin, Y. (2023) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2023.101201 · Cited by 7

Intestinal interoception: A nexus of environment-body-brain interactions

Salvador, A. F. M., Golynker, I., Betley, J. N., & Thaiss, C. A. (2026) · Neuron · doi:10.1016/j.neuron.2025.11.026 · Cited by 6

Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort Study

Pasculli, P., Zingaropoli, M. A., Dominelli, F., Solimini, A. G., Masci, G. M., Birtolo, L. I., Pasquariello, L., Paribeni, F., Iafrate, F., Panebianco, V., et al. (2024) · The American Journal of Medicine · doi:10.1016/j.amjmed.2024.09.006 · Cited by 5

Exploring common pathogenic association between Epstein Barr virus infection and long-COVID by integrating RNA-Seq and molecular dynamics simulations

Kanwal, A., & Zhang, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1435170 · Cited by 5

Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?

Al‐Khrasani, M., Essmat, N., Boldizsár, I., Varga, B. T., Chalabiani, Y., Abbood, S. K., Ernyey, A. J., Király, K. P., Máté, A., Riba, P., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118346 · Cited by 8

Favorable responses to upadacitinib, a JAK1 inhibitor, in long COVID patients with predominant neuropsychiatric symptoms: case reports in 2 autistic patients and one typically developing patient

Jyonouchi, H., Kornitzer, J., & Geng, L. (2025) · BMC Neurology · doi:10.1186/s12883-025-04341-y · Cited by 5

Are there cognitive and neuroimaging signatures in long COVID?

Matías‐Guiu, J. A., & Díez‐Cirarda, M. (2023) · Brain Communications · doi:10.1093/braincomms/fcad189 · Cited by 5

Update on Central Nervous System Effects of the Intersection of HIV-1 and SARS-CoV-2

Ocampo, F. F., Promsena, P., & Chan, P. (2023) · Current HIV/AIDS Reports · doi:10.1007/s11904-023-00676-8 · Cited by 5

Unmasking the mental health scars of COVID-19: A longitudinal investigation of children and adolescents in post-lockdown China

Zhu, Y., Yu, Y., Wang, Y., Womer, F. Y., Qin, X., Zhou, K., Zhu, R., Du, W., Yang, J., Su, K., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.003 · Cited by 5

Changes in Working Situations of Employed Long COVID Patients: Retrospective Study in Japanese Outpatient Clinic

Matsuda, Y., Sakurada, Y., Otsuka, Y., Tokumasu, K., Nakano, Y., Sunada, N., Honda, H., Hasegawa, T., Takase, R., Omura, D., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133809 · Cited by 5

New Evidence for the Role of the Blood-Brain Barrier and Inflammation in Stress-Associated Depression: A Gene-Environment Analysis Covering 19,296 Genes in 109,360 Humans

Gál, Z., Török, D., Gonda, X., Eszlári, N., Anderson, I. M., Deakin, J. F. W., Petschner, P., Juhász, G., & Bagdy, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011332 · Cited by 6

A Two-Year cohort study examining the impact of cytokines and chemokines on cognitive and psychiatric outcomes in Long-COVID-19 patients

Amendola, F. C., Roncete, G. P., Borges, S. A. M., Rocca, C. C. D. A., Serafim, A. D. P., de Castro, G. S., Seelaender, M. C. L., Miguel, E. C., Busatto, G. F., Forlenza, O. V., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.12.006 · Cited by 6

Navigating neurologic post-COVID-19 conditions in adults: Management strategies for cognitive dysfunction, headaches and neuropathies

Chopra, A., Franko, N., & Chow, E. J. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123374 · Cited by 5

Inflammatory predictors of Post-COVID fatigue

Nuber‐Champier, A., Bréville, G., Voruz, P., de Alcântara, I. J., Lalive, P. H., Allali, G., Benzakour, L., Lövblad, K., Braillard, O., Nehme, M., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106685 · Cited by 4

Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19

Havdal, L. B., Selvakumar, J. P., Berven, L. L., Stiansen-Sonerud, T., Zetterberg, H., Blennow, K., Holmøy, T., & Wyller, V. B. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1345787 · Cited by 4

Complications of COVID-19 on the Central Nervous System: Mechanisms and Potential Treatment for Easing Long COVID

Wei, Z. D., Liang, K., & Shetty, A. K. (2023) · Aging and Disease · doi:10.14336/ad.2023.0312 · Cited by 17

Neuroimmune pathophysiology of long COVID

Moen, J. K., Baker, C. A., & Iwasaki, A. (2025) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13855 · Cited by 38

Neurological Mechanisms of Long COVID

Hsia, T.-J. (2024) · Science Insights · doi:10.15354/si.24.re1059

Understanding the long-term neurological effects of SARS-CoV-2 infection

Matthews, R., Alam, A. M., Bullmore, E. T., & Michael, B. D. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01205-y · Cited by 8

Neurological Sequelae of Long COVID: Mechanisms, Clinical Impact and Emerging Therapeutic Insights

Ramli, M. D. C., Singh, B. K. D., Abidin, Z. Z., Azlan, A., Nurjannah, A., Hein, Z. M., Nassir, C. M. N. C. M., Thangarajan, R., Izham, N. A. M., & Kumar, S. (2025) · COVID · doi:10.3390/covid5120207 · Cited by 4